Grupo Farmaceutico Somar

Financings Total biopharma financing during the fourth quarter of 2017 amounted to $14.5 billion, a strong finish to a year that benefitted from renewed investor confidence in the industry and an open

Endo International PLC 's decision July 6 to accede to the US FDA's request that it withdraw its long-acting opioid Opana ER (oxymorphone extended-release) is not a huge business setback on its own

IN VITRO DIAGNOSTICS Mergers & Acquisitions Laboratory Corp. of America Holdings LipoScience Inc. Laboratory Corp. of America Holdings acquired publicly traded LipoScience Inc. (diagnostics fo

IN VITRO DIAGNOSTICS Mergers & Acquisitions Immucor Inc. Organ-I Inc. Immucor Inc. acquired fellow privately held transplant diagnostics company Organ-I Inc. (Jun.) Organ-I spun out of Stanf